BenzingaOctober 22, 2026 at 3:20 AM NY5 Days Ago
Baird Maintains Outperform on Abbott Laboratories, Raises Price Target to $123
Baird analyst David Rescott maintains Abbott Laboratories (NYSE:ABT) with a Outperform and raises the price target from $121 to $123.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
